Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Brief report: Artificial intelligence meets small cell lung cancer-integrating clinicopathological and wholeslide image data for prognostic prediction in SCLC.

Frontiers in artificial intelligence·2026

Same author

Computational Identification of Potential Novel Allosteric IHF Inhibitors Using QSAR Modeling to Inhibit Plasmid-Mediated Antibiotic Resistance.

International journal of molecular sciences·2026

Same author

Accelerating real-world prediction and research in Alzheimer's: The M3AD study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Same author

Dual Subsartorial Block: An Analgesic Technique Targeting the Popliteal Plexus of the Knee in Anterior Cruciate Ligament Reconstruction-A Case Series.

A&A practice·2026

Same author

Efficacy of a Standardized Low-Dose Insulin Infusion Protocol in the Emergency Stabilization of Diabetic Dogs.

Veterinary sciences·2025

Same author

Testing an augmented reality-based learning sequence for renal physiology with biomedical students.

Advances in physiology education·2025

Search research articles

相关实验视频

Updated: May 30, 2025

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Published on: November 23, 2019

一个简单的基于机器学习的定量结构-活动关系模型,用于预测FLT3氨酸激酶的pIC₅₀抑制值.

Jackson J Alcázar¹, Ignacio Sánchez¹, Cristian Merino¹

¹Centro de Química Médica, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago 7780272, Chile.

Pharmaceuticals (Basel, Switzerland)

|January 25, 2025

概括

这项研究开发了一种机器学习模型,用于预测急性髓性白血病 (AML) 治疗的FLT3抑制剂功效. 该模型提供了一个用户友好的工具,可以更快地发现药物,并开发有针对性的AML疗法.

关键词:

治疗AML的治疗方法 FLT3 抑制剂的使用.在QSAR建模中使用QSAR模型.计算机辅助药物设计基于带的药物设计.

更多相关视频

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

相关实验视频

Last Updated: May 30, 2025

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Published on: November 23, 2019

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

科学领域:

药用化学医学化学
计算化学计算化学
药理学药理学是指药理学的学科.

背景情况:

急性髓性白血病 (AML) 带来了治疗挑战,特别是FLT3突变病例.
现有的FLT3抑制剂模型在数据集大小,多样性和准确性方面存在局限性.

研究的目的:

为FLT3抑制剂开发一个强大的,用户友好的定量结构-活性关系 (QSAR) 模型.
预测抑制功效 (pIC50) 以帮助药物发现.

主要方法:

在一个大数据集 (1350个化合物,1269个描述符) 上训练了一个随机的森林回归器.
验证了模型使用离开一个,十倍交叉验证 (Q2=0.926) 和外部验证 (R2=0.941) 的方法.

主要成果:

确定了影响FLT3抑制剂功效的关键分子描述剂.
开发了一个用于快速pIC50预测和虚拟查的计算工具.
确定了有前途的新型FLT3抑制剂.

结论:

开发的QSAR模型显著推进了FLT3抑制剂的发现.
为AML早期药物开发提供了可靠和有效的方法.
加快了针对AML的向治疗方法的创建.